MiniMed Group Inc(MMED) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 16 at 4:22 PM ET (Korea 10/17 05:22)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | - | Insider Own | 90.36% | Shs Outstand | 281.2M | Perf Week | -11.26% |
| Market Cap | 4.92B | Forward P/E | 24.52 | EPS next Y | 1.97% | Insider Trans | - | Shs Float | 27.0M | Perf Month | -20.61% |
| Enterprise Value | 4.77B | PEG | - | EPS next Q | - | Inst Own | 13.26% | Short Float | 67.45% | Perf Quarter | 3.37% |
| Income | - | P/S | - | EPS this Y | 154.23% | Inst Trans | 1.89% | Short Ratio | 3.26 | Perf Half Y | 21.12% |
| Sales | - | P/B | 1.36 | EPS next 5Y | - | ROA | - | Short Interest | 18.20M | Perf YTD | -8.19% |
| Book/sh | 12.87 | P/C | 23.77 | EPS past 3/5Y | - | ROE | - | 52W High | -28.41% ($24.43) | Perf Year | - |
| Cash/sh | 0.74 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 64.23% ($10.65) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 6.91% 4.54% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.97 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.36 | EPS Q/Q | 100% | Profit Margin | - | RSI (14) | 35.9 | Recom | 1.53 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.81 | Sales Q/Q | 16.44% | SMA20 | -10.42% ($19.52) | Beta | - | Target Price | $25.87 |
| Payout | - | Debt/Eq | 0.02 | Earnings | 2026/9/1 | SMA50 | -14.49% ($20.45) | Rel Volume | 3.84 | Prev Close | $18 |
| Employees | 8000 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | -356.07% 1.01% | SMA200 | 6.12% ($16.48) | Avg Volume(3M) | 5.59M | Price | $17.49 |
| IPO | 2026/3/6 | Option/Short | Yes/Yes | Trades | 52473 | Volume | 21,451,518 | Change | -2.83% |
💉 A medical device company that provides diabetes management devices. It offers a diabetes management ecosystem including automated insulin pumps, continuous glucose monitors, and smart insulin pens, and was spun off from Medtronic before going public. The company is a diabetes device specialist equipped with an automated insulin delivery system.
Over the past 1 year, roughly in the middle
28% below its 1-year high.
Traded more than usual. That is 384% of its average volume.
Earnings are growing steadily
Earnings are expected to grow by +154.2% this year.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Long-term returns are roughly flat
Tap to view numbers
No dividend
There is no profit to distribute yet.
Short interest is a burden
67.5% of the float is sold short.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #18 of 51 in the industry
Based on market cap of $5B.
FAQ
What kind of company is MMED?
MMED belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of MMED?
The market cap of MMED is approximately $4.9B, ranking 1,361 within its sector.
What is the 52-week high and low for MMED?
MMED has recorded a 52-week high of $24.43 and a low of $10.65.
